Denying effective antiretroviral drugs to HIV-positive pregnant women the national government's flawed decision

South African Medical Journal

Volumn 89, Issue 6, 1999, Pages 621-623

  Lurie, M ^a   Lurie, P ^a   IJsselmuiden, C ^a   Gray, G ^a  

^a SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ZIDOVUDINE;

CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG INDUSTRY; EDITORIAL; GOVERNMENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAUTERINE INFECTION; PREGNANCY; PRENATAL DRUG EXPOSURE; PUBLIC HEALTH; SOUTH AFRICA;

ANTI-HIV AGENTS; COST-BENEFIT ANALYSIS; DISEASE TRANSMISSION, VERTICAL; DRUG COSTS; FEMALE; HEALTH POLICY; HIV SEROPOSITIVITY; HUMANS; INFANT; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; TREATMENT OUTCOME; ZIDOVUDINE;

EID: 0032771015     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (30)